Stockreport

Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors [Yahoo! Finance]

Intensity Therapeutics, Inc.  (INTS) 
PDF biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immu [Read more]